Summary
Johnson & Johnson (JNJ) filed an 8-K on October 16, 2012, to report its financial results for the third quarter ended September 30, 2012. This filing primarily includes a press release and supplementary financial data detailing the company's sales and earnings performance during the period. Investors should review the attached press release and unaudited condensed consolidated statements for a comprehensive understanding of the company's operational and financial condition as of that date.
Key Highlights
- 1Johnson & Johnson announced its third-quarter 2012 sales and earnings results.
- 2The report was filed on October 16, 2012, with the event date of October 15, 2012.
- 3The filing includes a press release detailing the quarterly financial performance.
- 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the third quarter are provided.
- 5This 8-K serves as the official disclosure of JNJ's Q3 2012 financial and operational outcomes.
Frequently Asked Questions
The main purpose of this 8-K filing is to announce Johnson & Johnson's financial results, specifically sales and earnings, for the third quarter ended September 30, 2012.
The filing includes a press release detailing the third-quarter results and unaudited comparative supplementary sales data along with condensed consolidated statements of earnings for the same period.
The detailed financial results are available within the press release and the supplementary financial statements attached as exhibits to this 8-K filing.
This particular 8-K primarily reports historical financial results for the third quarter of 2012. Any forward-looking statements or guidance would be found within the text of the attached press release, which is not fully detailed in the provided summary information.